A randomized trial of an NMDA receptor antagonist for reversing corticosteroid effects on the human hippocampus.
Brown ES, Kulikova A, Van Enkevort E, Nakamura A, Ivleva EI, Tustison NJ, Roberts J, Yassa MA, Choi C, Frol A, Khan DA, Vazquez M, Holmes T, Malone K.
Brown ES, et al.
Neuropsychopharmacology. 2019 Dec;44(13):2263-2267. doi: 10.1038/s41386-019-0430-8. Epub 2019 Jun 10.
Neuropsychopharmacology. 2019.
PMID: 31181564
Free PMC article.
Clinical Trial.